174 related articles for article (PubMed ID: 35062885)
1. Age-adjusted Charlson comorbidity index in recurrent glioblastoma: a new prognostic factor?
Barz M; Bette S; Janssen I; Aftahy AK; Huber T; Liesche-Starnecker F; Ryang YM; Wiestler B; Combs SE; Meyer B; Gempt J
BMC Neurol; 2022 Jan; 22(1):32. PubMed ID: 35062885
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of tumour volume in patients with a poor Karnofsky performance status scale - a bicentric retrospective study.
Barz M; Gerhardt J; Bette S; Aftahy AK; Huber T; Combs SE; Ryang YM; Wiestler B; Skardelly M; Gepfner-Tuma I; Behling F; Schmidt-Graf F; Meyer B; Gempt J
BMC Neurol; 2021 Nov; 21(1):446. PubMed ID: 34781889
[TBL] [Abstract][Full Text] [Related]
3. Impact of removed tumor volume and location on patient outcome in glioblastoma.
Awad AW; Karsy M; Sanai N; Spetzler R; Zhang Y; Xu Y; Mahan MA
J Neurooncol; 2017 Oct; 135(1):161-171. PubMed ID: 28685405
[TBL] [Abstract][Full Text] [Related]
4. Charlson comorbidity index: an additional prognostic parameter for preoperative glioblastoma patient stratification.
Ening G; Osterheld F; Capper D; Schmieder K; Brenke C
J Cancer Res Clin Oncol; 2015 Jun; 141(6):1131-7. PubMed ID: 25577223
[TBL] [Abstract][Full Text] [Related]
5. Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article.
Bloch O; Han SJ; Cha S; Sun MZ; Aghi MK; McDermott MW; Berger MS; Parsa AT
J Neurosurg; 2012 Dec; 117(6):1032-8. PubMed ID: 23039151
[TBL] [Abstract][Full Text] [Related]
6. Age-adjusted Charlson Comorbidity Index is a valuable prognostic tool in operable soft tissue sarcoma of trunk and extremities.
Telli TA; Alan O; Demircan NC; Sariyar N; Arikan R; Basoglu T; Yasar A; Celebi A; Isik S; Sofulu O; Erol B; Turkoz HK; Ozgen Z; Ercelep O; Dane F; Yumuk PF
Orthop Traumatol Surg Res; 2023 May; 109(3):103491. PubMed ID: 36455864
[TBL] [Abstract][Full Text] [Related]
7. The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?
Li YM; Suki D; Hess K; Sawaya R
J Neurosurg; 2016 Apr; 124(4):977-88. PubMed ID: 26495941
[TBL] [Abstract][Full Text] [Related]
8. Is age an additional factor in the treatment of elderly patients with glioblastoma? A new stratification model: an Italian Multicenter Study.
Ius T; Somma T; Altieri R; Angileri FF; Barbagallo GM; Cappabianca P; Certo F; Cofano F; D'Elia A; Della Pepa GM; Esposito V; Fontanella MM; Germanò A; Garbossa D; Isola M; La Rocca G; Maiuri F; Olivi A; Panciani PP; Pignotti F; Skrap M; Spena G; Sabatino G
Neurosurg Focus; 2020 Oct; 49(4):E13. PubMed ID: 33002864
[TBL] [Abstract][Full Text] [Related]
9. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
[TBL] [Abstract][Full Text] [Related]
10. An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity.
Oppenlander ME; Wolf AB; Snyder LA; Bina R; Wilson JR; Coons SW; Ashby LS; Brachman D; Nakaji P; Porter RW; Smith KA; Spetzler RF; Sanai N
J Neurosurg; 2014 Apr; 120(4):846-53. PubMed ID: 24484232
[TBL] [Abstract][Full Text] [Related]
11. Prognostic nutritional index as a prognostic marker in glioblastoma: Data from a cohort of 282 Italian patients.
Rigamonti A; Imbesi F; Silvani A; Lamperti E; Agostoni E; Porcu L; De Simone I; Torri V; Ciusani E; Bonato C; Salmaggi A
J Neurol Sci; 2019 May; 400():175-179. PubMed ID: 30974322
[TBL] [Abstract][Full Text] [Related]
12. Repeat-surgery at Glioblastoma recurrence, when and why to operate?
Ening G; Huynh MT; Schmieder K; Brenke C
Clin Neurol Neurosurg; 2015 Sep; 136():89-94. PubMed ID: 26092644
[TBL] [Abstract][Full Text] [Related]
13. Surgical outcome and molecular pattern characterization of recurrent glioblastoma multiforme: A single-center retrospective series.
Montemurro N; Fanelli GN; Scatena C; Ortenzi V; Pasqualetti F; Mazzanti CM; Morganti R; Paiar F; Naccarato AG; Perrini P
Clin Neurol Neurosurg; 2021 Aug; 207():106735. PubMed ID: 34119900
[TBL] [Abstract][Full Text] [Related]
14. Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma.
Grabowski MM; Recinos PF; Nowacki AS; Schroeder JL; Angelov L; Barnett GH; Vogelbaum MA
J Neurosurg; 2014 Nov; 121(5):1115-23. PubMed ID: 25192475
[TBL] [Abstract][Full Text] [Related]
15. Determining a cut-off residual tumor volume threshold for patients with newly diagnosed glioblastoma treated with temozolomide chemoradiotherapy: A multicenter cohort study.
Woo PYM; Ho JMK; Tse TPK; Lam SW; Mak CHK; Chan DTM; Lee MWY; Wong ST; Chan KY; Poon WS
J Clin Neurosci; 2019 May; 63():134-141. PubMed ID: 30712777
[TBL] [Abstract][Full Text] [Related]
16. Safety and outcomes of resection of butterfly glioblastoma.
Dayani F; Young JS; Bonte A; Chang EF; Theodosopoulos P; McDermott MW; Berger MS; Aghi MK
Neurosurg Focus; 2018 Jun; 44(6):E4. PubMed ID: 29852771
[TBL] [Abstract][Full Text] [Related]
17. The relationship between repeat resection and overall survival in patients with glioblastoma: a time-dependent analysis.
Goldman DA; Hovinga K; Reiner AS; Esquenazi Y; Tabar V; Panageas KS
J Neurosurg; 2018 Nov; 129(5):1231-1239. PubMed ID: 29303449
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of the Age-Adjusted Charlson Comorbidity Index (ACCI) on Short- and Long-Term Outcome in Patients with Advanced Primary Epithelial Ovarian Cancer.
Kahl A; du Bois A; Harter P; Prader S; Schneider S; Heitz F; Traut A; Alesina PF; Meier B; Walz M; Brueckner A; Groeben HT; Brunkhorst V; Heikaus S; Ataseven B
Ann Surg Oncol; 2017 Nov; 24(12):3692-3699. PubMed ID: 28871563
[TBL] [Abstract][Full Text] [Related]
19. Threshold of the extent of resection for WHO Grade III gliomas: retrospective volumetric analysis of 122 cases using intraoperative MRI.
Fujii Y; Muragaki Y; Maruyama T; Nitta M; Saito T; Ikuta S; Iseki H; Hongo K; Kawamata T
J Neurosurg; 2018 Jul; 129(1):1-9. PubMed ID: 28885120
[TBL] [Abstract][Full Text] [Related]
20. Clinical benefit from resection of recurrent glioblastomas: results of a multicenter study including 503 patients with recurrent glioblastomas undergoing surgical resection.
Ringel F; Pape H; Sabel M; Krex D; Bock HC; Misch M; Weyerbrock A; Westermaier T; Senft C; Schucht P; Meyer B; Simon M;
Neuro Oncol; 2016 Jan; 18(1):96-104. PubMed ID: 26243790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
